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Value of Physician-Scientists 
• Bridge worlds of science and medicine, 
bringing questions and observations to 
the “lab” and translating discovery to 
practice 
• Disproportionally represented in 
leadership positions 
• Illustrate justification of funding research 
for the public 
 
 
Abraham Flexner, 1925 
“…no distinction can be 
made between research 
and practice. The 
investigator, obviously, 
observes, experiments, 
and judges; so do the 
physician and surgeon 
who practice their art in 
the modern spirit. At 
bottom the intellectual 
attitude and processes of 
the two are—or should be 
–identical…” 
Challenges and Rewards 
• Lengthy training 
• Delayed gratification 
• Reduced income potential 
• Competing demands on 
time 
• Competition with research 
faculty for grants 
• Competition with clinical 
faculty for productivity 
• Temptation to over-commit 
 
 
• Broad view of relevance of 
their work 
• Satisfaction (albeit delayed) 
of seeing impact 
• Enhanced rate of 
advancement to leadership 
• Admiration of colleagues 
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NIH Appropriations in Current and Constant Dollars 
7 
Extramural Research Awards at UMMS: 
Fiscal Years 2006 - 2016 
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Research Project Grants 
 Competing applications, awards, and success rates 
 
Source: NIH Data Book http://report.nih.gov/nihdatabook/index.aspx 
and supplemental tables available in RePORT 
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Chart 13-14-1.  Average Age and Degree Type of First-Time Investigators 
on R01-Equivalent Grants* (Fiscal Years 1980-2013)** 
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*The definition of first time investigator has changed over time, and the annual numbers in the chart reflect the first time investigator policies that were in place during those years.  R01 Equivalents include 
activity codes R01, R23, R29, and R37, and beginning in 2008 included DP2 awards to first-time NIH investigators.  Not all these activities are in use by NIH every year. 
** Excludes American Reinvestment and Recovery Act Awards (ARRA). 
See associated blog post at http://nexus.od.nih.gov/all/category/blog/ 
Type of Classification Number of Awardees Average Age Median Age 
Early Stage Investigators2 785 39.2 39 
Targeted New Scientist Programs 
Number of 
Awardees Average Age Median Age 
Outstanding New Environmental Scientist (ONES) in 20111a <11 36.9 37 
Biobehavioral Research Award for Innovative New Scientist 
(BRAINS)1b <11 36.4 36 
NIH Director's New Innovator Award Program1c 45 37.4 37 
NIH Pathway to Independence Award (R00)3 153 36.2 36 
NIH Director's Early Independence Awards1d 14 32.1 32 
Research Career Development Awards  
(all K awards) 
 
Research Career Development Awards 
 Total funding and average size 
 
Individual Research Career Development Awards 
 Number of entry-level awards 
 
Institutional Research Career Development Awards 
 Number of entry-level appointments 
 
KL2 Program Sponsored by the UMass Center 
for Clinical and Translational Science  
 
KL2 Scholar 
Award Date # Successful Grant 
Proposals 
Total Amount # Journal Publications 
Olga Hardy Gupta, MD* 2007 1 $160,305 20  
Wendy K. Marsh, MD, MS 2008 1 $75,000 25  
Jeffrey Bailey, MD, PhD 2009 4 $22,454,338 18  
Sarah L. Cutrona, MD, MPH 2010 9 $2,534,760 22  
Heena P. Santry, MD 2010 2 $2,300,000 27  
David D. McManus, MD 2012 5 $3,188,612 74  
Nancy Byatt, DO, MD, FAPM 2013 5 $4,479,736 20  
Molly E. Waring, PhD 2013 1 $6,000 41  
Melissa Anderson, PhD 2014 2 $300,314 4  
Stephanie Carreiro, MD 2016 
Mara Epstein, ScD 2016 
 TOTALS   30 $35,499,065 251 
* Recruited to UTSW as endowed “Dedman Family Scholar in Clinical Care” in 2012 
Summary 
• Value of Physician-scientists remains 
central to mission of academic medicine 
• Challenges have stabilized but require 
ongoing affirmative efforts 
• Specific purposeful mechanisms must be 
developed to ensure ongoing viability of 
physician-scientist role 
